0

Full Content is available to subscribers

Subscribe/Learn More  >
Proceedings Article

Nanomedicine: nanoparticles, molecular biosensors, and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics

[+] Author Affiliations
Tarl W. Prow, Jose H. Salazar, William A. Rose, Jacob N. Smith, Lisa Reece, Andrea A. Fontenot, Nan A. Wang, James F. Leary

Univ. of Texas Medical Branch/Galveston (USA)

R. Stephen Lloyd

Oregon Health Sciences Ctr. (USA)

Proc. SPIE 5318, Advanced Biomedical and Clinical Diagnostic Systems II, 1 (July 1, 2004); doi:10.1117/12.547922
Text Size: A A A
From Conference Volume 5318

  • Advanced Biomedical and Clinical Diagnostic Systems II
  • Gerald E. Cohn; Warren S. Grundfest; David A. Benaron; Tuan Vo-Dinh
  • San Jose, CA | January 24, 2004

abstract

Next generation nanomedicine technologies are being developed to provide for continuous and linked molecular diagnostics and therapeutics. Research is being performed to develop "sentinel nanoparticles" which will seek out diseased (e.g. cancerous) cells, enter those living cells, and either perform repairs or induce those cells to die through apoptosis. These nanoparticles are envisioned as multifunctional "smart drug delivery systems". The nanosystems are being developed as multilayered nanoparticles (nanocrystals, nanocapsules) containing cell targeting molecules, intracellular re-targeting molecules, molecular biosensor molecules, and drugs/enzymes/gene therapy. These "nanomedicine systems" are being constructed to be autonomous, much like present-day vaccines, but will have sophisticated targeting, sensing, and feedback control systems-much more sophisticated than conventional antibody-based therapies. The fundamental concept of nanomedicine is to not to just kill all aberrant cells by surgery, radiation therapy, or chemotherapy. Rather it is to fix cells, when appropriate, one cell-at-a-time, to preserve and re-build organ systems. When cells should not be fixed, such as in cases where an improperly repaired cell might give rise to cancer cells, the nanomedical therapy would be to induce apoptosis in those cells to eliminate them without the damagin bystander effects of the inflammatory immune response system reacting to necrotic cells or those which have died from trauma or injury. The ultimate aim of nanomedicine is to combine diagnostics and therapeutics into "real-time medicine", using where possible in-vivo cytometry techniques for diagnostics and therapeutics. A number of individual components of these multi-component nanoparticles are already working in in-vitro and ex-vivo cell and tissue systems. Work has begun on construction of integrated nanomedical systems.

© (2004) COPYRIGHT SPIE--The International Society for Optical Engineering. Downloading of the abstract is permitted for personal use only.
Citation

Tarl W. Prow ; Jose H. Salazar ; William A. Rose ; Jacob N. Smith ; Lisa Reece, et al.
"Nanomedicine: nanoparticles, molecular biosensors, and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics", Proc. SPIE 5318, Advanced Biomedical and Clinical Diagnostic Systems II, 1 (July 1, 2004); doi:10.1117/12.547922; http://dx.doi.org/10.1117/12.547922


Access This Article
Sign In to Access Full Content
Please Wait... Processing your request... Please Wait.
Sign in or Create a personal account to Buy this article ($15 for members, $18 for non-members).
 

Figures

Tables

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Book Chapters

Topic Collections

Advertisement


Buy this article ($18 for members, $25 for non-members).
Sign In